Clinical Trial Update: Polio Vaccine (IPV) for SARS-CoV-2 and Prevention of Coronavirus Disease (COVID-19) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update involving an IPV-based approach for SARS-CoV-2 and COVID-19 prevention.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sars-cov-2

Drugs mentioned

• Polio Vaccine (IPV) (inactivated poliovirus vaccine)

Snippet

Sponsor: E-MO Biology Inc | Conditions: SARS-CoV-2 | Phase 4 | Status: UNKNOWN